Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : TM Bioscience Corp. tmc.v -- Ignore unavailable to you. Want to Upgrade?

To: Norm Gardner who wrote (53)	4/8/1998 8:27:00 PM
From: Norm Gardner	Read Replies (1) \| Respond to of 137

To ALL: TM News Release on additions to Scientific Advisory Board. NEWS RELEASE TRANSMITTED BY CANADIAN CORPORATE NEWS FOR: TM BIOSCIENCE CORPORATION 08 April 98 close $0.91 Shares issued: 43,788,656 VSE SYMBOL: TMC APRIL 8, 1998 Tm Bioscience Corporation: Additions to Scientific Advisory Board TORONTO, ONTARIO-- Mr. Don MacAdam reports: Tm Bioscience has increased the size of its Scientific Advisory Board to nine external members with the appointment of six prominent scientists: R. Christopher Bleackley, PhD, is a Professor in the Department of Biochemistry at the University of Alberta in Edmonton. He is a cellular biochemist and an expert on human disease and human gene therapy. Jerrie Gavalchin, PhD, is a Professor in the Department of Medicine at the State University of New York, Syracuse. She is an immunologist with particular expertise on immuno assay design and cellular immunology. J. Michael Schurr, PhD, is a Professor in the Department of Chemistry at the University of Washington, in Seattle. He is an expert on DNA sequence dependent polymorphic structure and dynamics in solution. Nadrian C. Seeman, PhD, is a Professor in the Department of Chemistry at New York University. He is an expert on DNA sequence dependent structure and molecular nanotechnology using DNA. Richard D. Sheardy, PhD, is a Professor and Chairman of the Department of Chemistry at Seton Hall University. He is an expert on DNA sequence dependent structure and synthesis of model compounds that bind DNAs. Roger M. Wartell, PhD, is a Professor and Head of the School of Biology at the Georgia Institute of Technology. He is an expert on DNA thermodynamics, sequence dependent cooperativity, stability and processing. These scientists join existing members: Jonathan B. Chaires, PhD, an expert on DNA thermodynamics and DNA/ligand interactions; Donald Low, MD, a bacteriologist and clinician and an expert on human infectious disease; and Bernard J. Poiesz, MD, a virologist and clinician and expert on human retroviruses. Tm Bioscience Corporation is a biotechnology company based in Toronto, Ontario, with a subsidiary Tm Technologies Inc. in Woburn, Massachusetts. The company has developed five platform technologies - biochips, therapeutics, gene expression, diagnostics and genomic analysis - each of which underlies multiple commercial products. -30-